Doubling down on Wnt signaling to overcome myeloma bone disease

wbldb

Delgado-Calle, Jesús^1,2; Roodman, G. David^3,4

J Bone Miner Res. June 2023;38(6):812-813

Cited Works (5)

Year	Entry
2004	Roodman GD. Mechanisms of bone metastasis. NEJM. April 15, 2004;350(16):1655-1664.
2023	Choi RB, Hoggatt AM, Horan DJ, Rogers EZ, Loots GG, Robling AG. Sostdc1 suppression in the absence of sclerostin potentiates anabolic action of cortical bone in mice. J Bone Miner Res. May 2023;38(5):765-774.
2023	Simic MK, Mohanty ST, Xiao Y, Cheng TL, Taylor VE, Charlat O, Croucher PI, McDonald MM. Multi-targeting DKK1 and LRP6 prevents bone loss and improves fracture resistance in multiple myeloma. J Bone Miner Res. June 2023;38(6):814-828.
2013	Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. February 2013;19(2):179-192.
2005	Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. May 2005;8(5):751-764.